Old Web
English
Sign In
Acemap
>
authorDetail
>
Richard Bruce Simonson
Richard Bruce Simonson
Janssen Pharmaceutica
Darunavir
Tenofovir alafenamide
Regimen
Medicine
Cobicistat
4
Papers
13
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Rapid initiation of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in acute and early HIV-1 infection: a DIAMOND subgroup analysis.
2021
Keith Dunn
Rachel Rogers
Richard Bruce Simonson
Donghan Luo
Shubin Sheng
Purnima T Kassam
Sareh Seyedkazemi
Hélène Hardy
Show All
Source
Cite
Save
Citations (0)
887. High Rates of Virologic Suppression Achieved in HIV-1–Infected Adults Rapidly Starting Antiretroviral Therapy (ART) with the Single-Tablet Regimen (STR) of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) 800/150/200/10 mg Regardless of Baseline Disease Characteristics: Week 48 Subgroup Analyses From the Phase 3 DIAMOND Trial
2019
Open Forum Infectious Diseases
Gregory D Huhn
Moti Ramgopal
Gordon Crofoot
Joseph Gathe
Sareh Seyedkazemi
Patricia Cosler
Richard Bruce Simonson
Donghan Luo
Keith Dunn
Show All
Source
Cite
Save
Citations (1)
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in a Rapid Initiation Model of Care for HIV-1 Infection: Primary Analysis of the DIAMOND Study
2019
Clinical Infectious Diseases
Gregory D Huhn
Gordon Crofoot
Moti Ramgopal
Joseph Gathe
Robert K. Bolan
Donghan Luo
Richard Bruce Simonson
Richard E. Nettles
Carmela Benson
Keith Dunn
Show All
Source
Cite
Save
Citations (10)
Impact of Splitting or Crushing on the Relative Bioavailability of the Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single‐Tablet Regimen
2019
Clinical pharmacology in drug development
Kimberley Brown
David Thomas
Kevin McKenney
Michael Reeder
Richard Bruce Simonson
Ceyhun Bicer
Richard E. Nettles
Herta Crauwels
Show All
Source
Cite
Save
Citations (2)
1